These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9198853)

  • 21. [Surgical treatment of resistant ascites in patients with portal hypertension].
    Eramishantsev AK; Lebezev VM; Musin RA
    Khirurgiia (Mosk); 2003; (4):4-8. PubMed ID: 12744126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of refractory ascites using a transjugular intrahepatic portosystemic shunt (TIPS). Clinical case].
    Zapata R; Fava M
    Rev Med Chil; 1999 Oct; 127(10):1229-35. PubMed ID: 10835740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paracentesis in the treatment of ascites in cirrhotic patients].
    Uriz Otano J; Sort P; Arroyo V
    Gastroenterol Hepatol; 1999; 22(7):356-63. PubMed ID: 10535210
    [No Abstract]   [Full Text] [Related]  

  • 27. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of patients with portal hypertension complicated by resistant ascites].
    Ibadil'din AS; Andreev GN; Tripol'skaia GI; Akhmetova ZhD
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):32-5. PubMed ID: 4060505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of peritoneal port-systems in the treatment of diuretic-resistant cirrhotic ascites].
    Abdurakhmanov BA; Gantsev ShKh; Kulakeev OK
    Khirurgiia (Mosk); 2010; (4):30-3. PubMed ID: 20517235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of ascites in liver cirrhosis].
    Gramkow M; Christensen E
    Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of ascites in liver cirrhosis].
    Beaugrand M
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T25-8. PubMed ID: 8045356
    [No Abstract]   [Full Text] [Related]  

  • 35. Ascites and Chronic Liver Disease in Children.
    Bolia R; Srivastava A
    Indian J Pediatr; 2024 Mar; 91(3):270-279. PubMed ID: 37310583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis and therapy of ascites in hepatic cirrhosis].
    Persico L
    Policlinico Prat; 1971 Feb; 78(3):100-9. PubMed ID: 5572866
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ascites: old and new remedies.
    Inturri P; Graziotto A; Rossaro L
    Dig Dis; 1996; 14(3):145-56. PubMed ID: 8861522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of portal hypertension by portosystemic shunts].
    Rössle M; Siegerstetter V; Huber M
    Ther Umsch; 1998 Feb; 55(2):89-96. PubMed ID: 9545850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
    Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
    Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.